Conagra Brands Inc
NYSE:CAG
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
26.48
32.83
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Conagra Brands Inc
Accounts Receivables
Conagra Brands Inc
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Conagra Brands Inc
NYSE:CAG
|
Accounts Receivables
$933.4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-1%
|
||
Hershey Co
NYSE:HSY
|
Accounts Receivables
$1.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
||
General Mills Inc
NYSE:GIS
|
Accounts Receivables
$1.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
1%
|
||
Kellogg Co
NYSE:K
|
Accounts Receivables
$1.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
||
Kraft Heinz Co
NASDAQ:KHC
|
Accounts Receivables
$2.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
||
Mondelez International Inc
NASDAQ:MDLZ
|
Accounts Receivables
$3.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-3%
|
Conagra Brands Inc
Glance View
Conagra Brands Inc. is a prominent player in the North American packaged foods industry, renowned for its wide-ranging portfolio of beloved brands that cater to evolving consumer tastes and dining trends. Founded over a century ago, Conagra has successfully evolved from its agricultural roots to become a leader in prepared, frozen, and shelf-stable foods. The company's offerings include iconic products like Marie Callender's, Healthy Choice, and Reddi-wip, appealing to both busy families and health-conscious consumers. By focusing on innovation and quality, Conagra has positioned itself to capture market share in a competitive landscape, responding adeptly to shifts in consumer preferences towards convenience, sustainability, and health. Investors looking at Conagra Brands will find a company that not only prioritizes growth through strategic acquisitions and product development but also demonstrates a commitment to financial stability and shareholder value. With a solid track record of consistent revenue growth and profitability, Conagra continuously returns capital to its shareholders through dividends and share-buyback programs. The company’s focus on increasing operational efficiency, coupled with its responsiveness to market trends, makes it a compelling choice for investors seeking exposure to the dynamic food sector. As consumer behaviors evolve, Conagra is poised to leverage its diverse brand portfolio and robust distribution network, ensuring it remains a staple on grocery shelves and a relevant player in the industry's future.
See Also
What is Conagra Brands Inc's Accounts Receivables?
Accounts Receivables
933.4m
USD
Based on the financial report for Aug 25, 2024, Conagra Brands Inc's Accounts Receivables amounts to 933.4m USD.
What is Conagra Brands Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
-1%
Over the last year, the Accounts Receivables growth was -4%. The average annual Accounts Receivables growth rates for Conagra Brands Inc have been 4% over the past three years , 4% over the past five years , and -1% over the past ten years .